Nonconvulsive status epilepticus: The role of morphine and its antagonist

Neurophysiologie Clinique

Volumn 30, Issue 2, 2000, Pages 109-112

  Bertran, F ^a   Denise, P ^a   Letellier, P ^b  

^a Ctr H   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Epileptogenesis; Morphine; Naloxone; Nonconvulsive status epilepticus

Indexed keywords

MORPHINE; NALOXONE;

AGED; ARTICLE; BACKACHE; BONE METASTASIS; CASE REPORT; DRUG EFFECT; EPILEPTIC STATE; FEMALE; HUMAN; LYMPHOMA; TONIC CLONIC SEIZURE;

EID: 0034030081     PISSN: 09877053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0987-7053(00)00059-9     Document Type: Article

References (25)

1. Aguglia U., Tinuper P., Farnarier G. État confusionnel critique prolongé à point de départ frontal chez le sujet âgé. Rev Electroencephalogr Neurophysiol Clin. 13:1983;174-179.
2. Bartolomei F., Gastaut J.L. Complex Partial Status epilepticus provoked by hyponatremia. Eur Neurol. 40:1998;53-54.
3. Cascino G.D. Nonconvulsive status epilepticus in adults and children. Epilepsia. 34:(Suppl 1):1993;21-28.
4. Engel J. Jr, Ackermann R.F., Caldecott-Hazard S., Chugani H.T. Do altered opioid mechanisms play a role in human epilepsy? Fariello R. Neurotransmitters, seizures, and epilepsy II. ? 1984;263-274 New-York: Raven Press.
5. Favale E., Rubino V., Mainardi P., Lunardi G., Albano C. Anticonvulsant effect of fluoxetine in humans. Neurology. 45:1995;1926-1927.
6. Frenck H. Pro- and anticonvulsivant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems. Brain Res Rev. 6:1983;197-210.
7. Frost J.J., Mayberg H.S., Fisher R.S. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neurol. 23:1988;231-237.
8. Gigli G.L., Diomedi M., Troisi A., Baldinetti F., Marciani M.G., Girolami E. Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy. Seizure. 3:1994;221-224.
9. Granner M.A., Lee S.I. Nonconvulsive status epilepticus: EEG analysis in a large series. Epilepsia. 35:1994;42-47.
10. Herzlinger R.A., Kandall S.R., Vaughan H.G. Neonatal seizures associated with narcotic withdrawal. J Pediatr. 91:1977;638-641.
11. Kudo T., Sato K., Yagi K., Seino M. Can absence status epilepticus be of frontal lobe origin? Acta Neurol Scand. 92:1995;472-477.
12. Leander J.D. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide. Epilepsia. 33:1992;573-576.
13. Mariani P.J. Seizures associated with low-dose naloxone. Am J Emerg M. 7:1989;127-129.
14. Molaie M., Kadzielawa K. Effect of naloxone infusion on the rate of epileptiform discharges in patients with complex partial seizures. Epilepsia. 30:1989;194-200.
15. Niedermeyer E., Fineyre F., Riley T., Uematsu S. Absence status (petit mal status) with focal characteristics. Arch Neurol. 36:1979;417-421.
16. Nowack W.J., King J.A. Triphasic waves and spike wave stupor. Clin Electroencephalogr. 23:1992;100-104.
17. Prasher V.P. Seizures associated with fluoxetine therapy. Seizure. 4:1993;315-317.
18. Rey M., Papy J.J. États d'obnubilation critique d'origine frontale : un diagnostic clinique difficile. Rev Electroencephalogr Neurophysiol Clin. 17:1987;377-385.
19. Rohr-Le Floch J., Gauthier G., Beaumanoir A. États confusionnels d'origine épileptique : intérêt de l'EEG en urgence. Rev Neurol. 144:1988;425-436.
20. Shorvon S. Status epilepticus, its clinical features and treatment in children and adults. 1994;Cambridge: Cambridge University Press.
21. Thomas P., Beaumanoir A., Genton P., Dolisi C., Chatel M. 'De novo' absence status of late onset: report of 11 cases. Neurology. 42:1992;104-110.
22. Thomas P., Zifkin B., Migneco O., Lebrun C., Darcourt J., Andermann F. Non convulsive status epilepticus of frontal origin. Neurology. 52:1999;1174-1183.
23. Tomson T., Lindbom U., Nilsson B.Y. Nonconvulsive status epilepticus in adults: thirty-two consecutive patients from a general hospital population. Epilepsia. 33:1992;829-835.
24. VanSweden B., Mellerio F. Toxic ictal confusion. J Epilepsy. 1:1988;157-163.
25. Wernicke J.F. The side effect profile and safety of fluoxetine. J Clin Psychiatry. 46:1985;59-67.